Victoria Ceperuelo-Mallafré1,2, Gemma Llauradó2,3, Noelia Keiran1,2, Ester Benaiges1,2, Brenno Astiarraga1,2,4, Laia Martínez1, Silvia Pellitero2,5, Jose Miguel González-Clemente2,6, Amaia Rodríguez7, José Manuel Fernández-Real4, Albert Lecube8, Ana Megía1,2, Nuria Vilarrasa2,9, Joan Vendrell10,2,11, Sonia Fernández-Veledo10,2. 1. Institut d'Investigació Sanitària Pere Virgili, Endocrinology and Nutrition Service, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain. 2. CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM)-Instituto de Salud Carlos III (ISCIII), Madrid, Spain. 3. Department of Endocrinology and Nutrition, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain. 4. Department of Diabetes, Endocrinology and Nutrition, Institut d'Investigació Biomèdica de Girona, CIBEROBN (CB06/03/010) and ISCIII, Girona, Spain. 5. Department of Endocrinology and Nutrition, Germans Trias i Pujol Research Institute, Barcelona, Spain. 6. Department of Endocrinology and Nutrition, Hospital de Sabadell, Corporació Sanitària Parc Taulí, Institut d'Investigació i Innovació Parc Taulí (Universitat Autònoma de Barcelona), Sabadell, Spain. 7. Metabolic Research Laboratory, Clínica Universidad de Navarra, CIBEROBN, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain. 8. Endocrinology and Nutrition Department, Hospital Universitari Arnau de Vilanova, Lleida, Spain. 9. Obesity Unit and Endocrinology and Nutrition Departments, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain. 10. Institut d'Investigació Sanitària Pere Virgili, Endocrinology and Nutrition Service, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain sonia.fernandezveledo@gmail.com jvo@comt.es. 11. Rovira I Virgili University, Tarragona, Spain.
Abstract
OBJECTIVE: To determine the potential use of baseline circulating succinate to predict type 2 diabetes remission after bariatric surgery. RESEARCH DESIGN AND METHODS: Forty-five obese patients with diabetes were randomly assigned to Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), or laparoscopic greater curvature plication. Anthropometric parameters were evaluated, and a complete biochemical analysis including circulating serum succinate concentrations was performed at baseline and 1 year after surgery. The results were externally validated in a second cohort including 88 obese patients with diabetes assigned to RYGB or SG based on clinical criteria. RESULTS: Succinate baseline concentrations were an independent predictor of diabetes remission after bariatric surgery. Patients achieving remission after 1 year had lower levels of baseline succinate (47.8 [37.6-64.6] µmol/L vs. 64.1 [52.5-82.9] µmol/L; P = 0.018). Moreover, succinate concentrations were significantly decreased 1 year after surgery (58.9 [46.4-82.4] µmol/L vs. 46.0 [35.8-65.3] µmol/L, P = 0.005). In multivariate analysis, the best logistic regression model showed that baseline succinate (odds ratio [OR] 11.3, P = 0.031) and the type of surgery (OR 26.4, P = 0.010) were independently associated with remission. The C-statistic for this model was 0.899 (95% CI 0.809-0.989) in the derivation cohort, which significantly improved the prediction of remission compared with current available scores, and 0.729 (95% CI 0.612-0.846) in the validation cohort. Interestingly, patients had a different response to the type of surgery according to baseline succinate, with significant differences in remission rates. CONCLUSIONS: Circulating succinate is reduced after bariatric surgery. Baseline succinate levels have predictive value for diabetes remission independently of previously described presurgical factors and improve upon the current available scores to predict remission.
RCT Entities:
OBJECTIVE: To determine the potential use of baseline circulating succinate to predict type 2 diabetes remission after bariatric surgery. RESEARCH DESIGN AND METHODS: Forty-five obesepatients with diabetes were randomly assigned to Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), or laparoscopic greater curvature plication. Anthropometric parameters were evaluated, and a complete biochemical analysis including circulating serum succinate concentrations was performed at baseline and 1 year after surgery. The results were externally validated in a second cohort including 88 obesepatients with diabetes assigned to RYGB or SG based on clinical criteria. RESULTS:Succinate baseline concentrations were an independent predictor of diabetes remission after bariatric surgery. Patients achieving remission after 1 year had lower levels of baseline succinate (47.8 [37.6-64.6] µmol/L vs. 64.1 [52.5-82.9] µmol/L; P = 0.018). Moreover, succinate concentrations were significantly decreased 1 year after surgery (58.9 [46.4-82.4] µmol/L vs. 46.0 [35.8-65.3] µmol/L, P = 0.005). In multivariate analysis, the best logistic regression model showed that baseline succinate (odds ratio [OR] 11.3, P = 0.031) and the type of surgery (OR 26.4, P = 0.010) were independently associated with remission. The C-statistic for this model was 0.899 (95% CI 0.809-0.989) in the derivation cohort, which significantly improved the prediction of remission compared with current available scores, and 0.729 (95% CI 0.612-0.846) in the validation cohort. Interestingly, patients had a different response to the type of surgery according to baseline succinate, with significant differences in remission rates. CONCLUSIONS: Circulating succinate is reduced after bariatric surgery. Baseline succinate levels have predictive value for diabetes remission independently of previously described presurgical factors and improve upon the current available scores to predict remission.
Authors: Yu A An; Shiuhwei Chen; Yingfeng Deng; Zhao V Wang; Jan-Bernd Funcke; Manasi Shah; Bo Shan; Ruth Gordillo; Jun Yoshino; Samuel Klein; Christine M Kusminski; Philipp E Scherer Journal: J Hepatol Date: 2021-03-18 Impact factor: 30.083
Authors: Adriana Sierra; Sol Otero; Eva Rodríguez; Anna Faura; María Vera; Marta Riera; Vanesa Palau; Xavier Durán; Anna Costa-Garrido; Laia Sans; Eva Márquez; Vladimir Poposki; Josep Franch-Nadal; Xavier Mundet; Anna Oliveras; Marta Crespo; Julio Pascual; Clara Barrios Journal: J Clin Med Date: 2022-03-05 Impact factor: 4.241
Authors: Brenno Astiarraga; Laia Martínez; Victoria Ceperuelo-Mallafré; Gemma Llauradó; Margarida Terrón-Puig; M Mar Rodríguez; Anna Casajoana; Silvia Pellitero; Ana Megía; Núria Vilarrasa; Joan Vendrell; Sonia Fernández-Veledo Journal: Diabetes Care Date: 2020-07-31 Impact factor: 19.112
Authors: Svati H Shah; Blandine Laferrère; Lydia Coulter Kwee; Olga Ilkayeva; Michael J Muehlbauer; Nathan Bihlmeyer; Bruce Wolfe; Jonathan Q Purnell; F Xavier Pi-Sunyer; Haiying Chen; Judy Bahnson; Christopher B Newgard Journal: Nutr Diabetes Date: 2021-02-24 Impact factor: 5.097
Authors: Francisco J Osuna-Prieto; Borja Martinez-Tellez; Jonatan R Ruiz; Sonia Fernández-Veledo; Lourdes Ortiz-Alvarez; Xinyu Di; Lucas Jurado-Fasoli; Huiwen Xu; Victoria Ceperuelo-Mallafré; Catalina Núñez-Roa; Isabelle Kohler; Antonio Segura-Carretero; José V García-Lario; Angel Gil; Concepción M Aguilera; Jose M Llamas-Elvira; Patrick C N Rensen; Joan Vendrell Journal: Cardiovasc Diabetol Date: 2021-07-27 Impact factor: 9.951